During a CII conference in Hyderabad, senior officials called for a proactive safety culture in the pharmaceutical sector to boost global competitiveness. The focus remains on integrating AI and IoT to secure Telangana's position as a life sciences capital.

Key Takeaways

  • Call to transform Telangana into the world's safest pharmaceutical manufacturing destination.
  • Safety should be viewed as a competitive driver, not just a compliance requirement.
  • Emphasis on integrating AI, IoT, and drone-based inspections.
  • Innovation, quality, and safety identified as the three pillars of the ecosystem.

At a recent Confederation of Indian Industry (CII) conference in Hyderabad, Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, made a powerful pitch to the pharmaceutical industry. He underscored the necessity of viewing safety as a core driver of global competitiveness rather than a mere regulatory checkbox.

Addressing the conference themed ‘Pillars of Protection – Forging a Safer Future for Pharma and Chemical Manufacturing,’ Singh highlighted that as the global vaccine capital, Telangana holds a profound responsibility. He urged stakeholders to foster a proactive safety culture through continuous incident reporting and the adoption of cutting-edge technologies.

Why This Matters

BozokMedia analysis shows that in an era of stringent global supply chain audits, a state's safety record directly dictates its ability to attract high-value pharmaceutical investments. Transitioning from 'compliance-based safety' to 'safety-by-design' is critical for long-term economic resilience.

Scale without safety is a liability and growth without resilience is unsustainable.

The industry leaders emphasized the deployment of Artificial Intelligence (AI), Internet of Things (IoT), digital twins, wearables, and drone-based inspections to mitigate risks. Chakravarthi AVPS, Convener of the CII Telangana Pharma and Life Sciences Panel, reinforced this by stating that safety must be embedded as a core business philosophy.

Historical Background

Telangana, led by Hyderabad, has long been the backbone of India's pharmaceutical prowess. With massive clusters dedicated to bulk drugs and biologics, the region has transitioned from a manufacturing hub to a global innovation center, necessitating this shift toward advanced safety protocols.

Did You Know?: Hyderabad is often referred to as the 'Pharma Capital of India,' contributing significantly to the global supply of generic medicines and vaccines.

Frequently Asked Questions

Question 1: What are the three pillars of the Life Sciences ecosystem according to officials?
Answer: The three pillars are innovation, quality, and safety.

Question 2: Which technologies are recommended for safer manufacturing?
Answer: AI, IoT, digital twins, wearables, and drone-based inspections are recommended.